ARCA biopharma, Inc. 4
4 · ARCA biopharma, Inc. · Filed Sep 21, 2015
Insider Transaction Report
Form 4
BRISTOW MICHAEL R
DirectorChief Science and Med. Officer
Transactions
- Sale
Common Stock
2015-09-18$6.33/sh−1,809$11,451→ 46,086 total
Holdings
- 19,986(indirect: By Trust)
Common Stock
- 25,459(indirect: By IRA)
Common Stock
Footnotes (4)
- [F1]Represents shares of common stock sold pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person for satisfaction of their tax withholding obligation with respect to the vesting of previously reported Restricted Stock Units ("RSUs") granted to the Reporting Person under the Issuer's 2013 Equity Incentive Plan (the "Plan").
- [F2]Includes (i) remaining 5,952 previously reported shares issued as RSUs under the Plan that vests on 9/17/16, (ii) 6,075 previously reported shares issued as RSUs under the Plan that vest in three equal annual installments beginning on 2/27/16, and (iii) 6,871 previously reported shares issued as RSUs under the Plan that vest in three equal annual installments beginning April 2, 2016, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined under the Plan; and 27,188 previously reported shares of common stock held directly.
- [F3]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $6.33 to $6.35. Upon request of the SEC staff, ARCA biopharma, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.
- [F4]Includes 118 shares that were inadvertently omitted from the prior filing.